Zaremba Rabourn Amy 4
4 · Ocuphire Pharma, Inc. · Filed Jan 22, 2024
Insider Transaction Report
Form 4
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
- Award
Common Stock
2024-01-18+40,000→ 82,658 total - Award
Employee Stock Option (right to buy)
2024-01-18+60,000→ 60,000 totalExercise: $2.77Exp: 2034-01-17→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024.
- [F2]The option will vest with respect to 15,000 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter.